Compounds > 1-methyl-3-isobutylxanthine
Page last updated: 2024-10-29

1-methyl-3-isobutylxanthine and Delayed Effects, Prenatal Exposure

1-methyl-3-isobutylxanthine has been researched along with Delayed Effects, Prenatal Exposure in 1 studies

1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jobe, AH1
Ikegami, M1
Padbury, J1
Polk, DH1
Korirnilli, A1
Gonzales, LW1
Ballard, PL1

Other Studies

1 other study available for 1-methyl-3-isobutylxanthine and Delayed Effects, Prenatal Exposure

ArticleYear
Combined effects of fetal beta agonist stimulation and glucocorticoids on lung function of preterm lambs.
    Biology of the neonate, 1997, Volume: 72, Issue:5

    Topics: 1-Methyl-3-isobutylxanthine; Adrenergic beta-Agonists; Animals; Betamethasone; Bucladesine; Ethanola

1997